Fischer M. Frank's most recent trade in NeuroPace Inc was a trade of 8,745 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 8,745 | 8,745 | - | - | Stock Option (right to buy) | |
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 17,774 | 17,774 | - | - | Stock Option (Rt to Buy) | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 1,159 | 57,500 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Fischer M. Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 778 | 56,341 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 871 | 55,563 (0%) | 0% | 0 | Common Stock | |
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 4.49 per share. | 30 Jun 2023 | 4,469 | 570,126 | - | 4.5 | 20,066 | Common Stock |
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 6.97 per share. | 30 Jun 2023 | 3,407 | 583,216 | - | 7.0 | 23,747 | Common Stock |
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 7.56 per share. | 30 Jun 2023 | 3,141 | 579,809 | - | 7.6 | 23,746 | Common Stock |
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 9.73 per share. | 30 Jun 2023 | 2,440 | 572,566 | - | 9.7 | 23,741 | Common Stock |
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 10.31 per share. | 30 Jun 2023 | 2,303 | 574,869 | - | 10.3 | 23,744 | Common Stock |
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 10.41 per share. | 30 Jun 2023 | 2,281 | 589,531 | - | 10.4 | 23,745 | Common Stock |
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 11.53 per share. | 30 Jun 2023 | 2,059 | 585,275 | - | 11.5 | 23,740 | Common Stock |
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 12.02 per share. | 30 Jun 2023 | 1,975 | 587,250 | - | 12.0 | 23,740 | Common Stock |
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 13.20 per share. | 30 Jun 2023 | 1,799 | 576,668 | - | 13.2 | 23,747 | Common Stock |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 658 | 54,692 (0%) | 0% | 0 | Common Stock | |
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 27,380 | 27,380 | - | - | Stock Option (Rt to Buy) | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 6,754 | 54,034 (0%) | 0% | 0 | Common Stock | |
| Tenon Medical Inc | Frank M. Fischer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.62 per share. | 22 May 2023 | 6,207 | 6,207 | - | 1.6 | 10,055 | Common Stock |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 463 | 47,280 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 422 | 46,817 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 359 | 46,395 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 382 | 46,036 (0%) | 0% | 0 | Common Stock | |
| NeuroPace Inc | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 18,253 | 18,253 | - | - | Stock Option (Right to Buy) | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 4,155 | 45,654 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 231 | 41,499 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 143 | 41,062 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 101 | 40,919 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 1,167 | 40,818 (0%) | 0% | 0 | Common Stock | |
| NeuroPace Inc | Frank M. Fischer | Director | 26 Apr 2021 | 472,366 | 565,657 | - | 0 | Common Stock | ||
| NeuroPace Inc | Frank M. Fischer | Director | 26 Apr 2021 | 450,880 | 0 | - | - | Series B Preferred Stock | ||
| NeuroPace Inc | Frank M. Fischer | Director | 26 Apr 2021 | 21,486 | 0 | - | - | Series A Preferred Stock | ||
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 120 | 39,651 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2020 | 96 | 39,531 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Frank M. Fischer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 120 | 39,435 (0%) | 0% | 0 | Common Stock |